|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product | |||||
| License | |||||
| Royalty | |||||
| Total revenues | |||||
| Operating expenses (income): | |||||
| Cost of revenues | |||||
| Research and development | |||||
| Gain on sale of Verdeca | |||||
| Loss on sale of Arcadia Spain | |||||
| GoodWheat | |||||
| Impairment of intangible assets | |||||
| Gain on sale of property and equipment | |||||
| Impairment of property and equipment | |||||
| Impairment of ROU asset | |||||
| Change in fair value of contingent consideration | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Credit loss | |||||
| Other income, net | |||||
| Valuation loss on March 2023 PIPE | |||||
| Change in fair value of common stock warrant and option liabilities | |||||
| Issuance and offering costs allocated to liability classified options | |||||
| Net loss from continuing operations before income taxes | |||||
| Income tax expense | |||||
| Net loss from continuing operations | |||||
| Net loss from discontinued operations | |||||
| Body Care | |||||
| GoodWheat | |||||
| Total net loss from discontinued operations | |||||
| Net loss | |||||
| Net loss attributable to non-controlling interest | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per share attributable to common stockholders: | |||||
| Basic net loss per share attributable to common stockholders from continuing operations | |||||
| Diluted net loss per share attributable to common stockholders from continuing operations | |||||
| Basic net loss per share attributable to common stockholders from discontinued operations | |||||
| Diluted net loss per share attributable to common stockholders from discontinued operations | |||||
| Net loss per basic share attributable to common stockholders | |||||
| Net loss per diluted share attributable to common stockholders | |||||
| Weighted-average number of shares used in per share calculations: | |||||
| Weighted average shares - Basic | |||||
| Weighted average shares - Diluted | |||||
| Unrealized gains on available-for-sale securities | |||||
| Reclassification adjustment for gains on available-for-sale securities included in net loss | |||||
| Change in unrealized gains on available-for-sale securities | |||||
| Comprehensive loss | |||||
Loading...